NANOG and glioblastoma: Conversely, ALKBH5 repression decreased tumorsphere formation and downregulated the TFs SOX2, Nanog, and Oct4, contributing to the self-renewal capacity of glioblastoma stem cells and breast CSCs [154, 155].